Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
3.685
-0.015 (-0.41%)
Nov 13, 2025, 12:37 PM CET
-0.41%
Market Cap1.31B
Revenue (ttm)100.00K
Net Income (ttm)-58.91M
Shares Out352.99M
EPS (ttm)-0.22
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume323,283
Average Volume1,615,394
Open3.700
Previous Close3.700
Day's Range3.640 - 3.710
52-Week Range1.400 - 4.990
Beta0.11
RSI54.32
Earnings DateFeb 26, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 9
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.